Abstract
Infusion of donor bone marrow (DBM)-derived cells continue to be tested in clinical protocols intended to induce specific immunologic tolerance. Central clonal deletion of donor-specific alloreactive cells associated with mixed chimerism reliably produced long-term graft tolerance. In this setting, depletion of recipient T cells by antilymphocyte antibodies and subsequent repopulation by donor hematopoietic cells after donor bone marrow infusion (DBMI) are prerequisites for tolerance induction. Major advances have been made in animal models and in pilot clinical trials and the key questions with the future perspectives are presented in this article.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 105-115 |
| Number of pages | 11 |
| Journal | Transplant Immunology |
| Volume | 13 |
| Issue number | 2 |
| DOIs | |
| State | Published - Jan 1 2004 |
Keywords
- Bone marrow transplant
- Chimerism
- Tolerance
ASJC Scopus subject areas
- Immunology
- Immunology and Allergy
- Transplantation
Fingerprint Dive into the research topics of 'Donor bone marrow transplantation: Chimerism and tolerance'. Together they form a unique fingerprint.
Cite this
Delis, S., Ciancio, G., Burke, G. W., Garcia-Morales, R., & Miller, J. (2004). Donor bone marrow transplantation: Chimerism and tolerance. Transplant Immunology, 13(2), 105-115. https://doi.org/10.1016/j.trim.2004.05.006